Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis
This qualitative study (n=13) aimed to investigate the psychological mechanisms of change in psilocybin-assisted psychotherapy (PAT) for alcoholism (AUD). Participants reported that psilocybin treatment helped them process emotions related to past events, promoting self-compassion, self-awareness, and feelings of interconnectedness, which laid the foundation for better regulation of negative emotions and improved quality of relationships. The study suggests that integrating self-compassion training with psychedelic therapy may enhance psychological outcomes in treating AUD.
Authors
- Michael Bogenschutz
- Gabrielle Agin-Liebes
- Elizabeth Nielson
Published
Abstract
Objective
The primary aim of this qualitative study was to delineate psychological mechanisms of change in the first randomized controlled trial of psilocybin-assisted psychotherapy to treat alcohol use disorder (AUD). Theories regarding psychological processes involved in psychedelic therapy remain underdeveloped.
Method
Participants (N = 13) mostly identified as non-Hispanic and White, with approximately equal proportions of cisgender men and women. Participants engaged in semistructured interviews about their subjective experiences in the study. Questions probed the nature of participants’ drinking before and after the study as well as coping patterns in response to strong emotions, stress, and cravings for alcohol. Verbatim transcripts were coded using Dedoose software, and content was analyzed with interpretive phenomenological analysis.
Results
Participants reported that the psilocybin treatment helped them process emotions related to painful past events and helped promote states of self-compassion, self-awareness, and feelings of interconnectedness. The acute states during the psilocybin sessions were described as laying the foundation for developing more self-compassionate regulation of negative affect. Participants also described newfound feelings of belonging and an improved quality of relationships following the treatment.
Conclusion
Our results support the assertion that psilocybin increases the malleability of self-related processing, and diminishes shame-based and self-critical thought patterns while improving affect regulation and reducing alcohol cravings. These findings suggest that psychosocial treatments that integrate self-compassion training with psychedelic therapy may serve as a useful tool for enhancing psychological outcomes in the treatment of AUD.
Research Summary of 'Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis'
Introduction
Alcohol use disorder (AUD) is highly prevalent and disabling, yet most people with AUD never access treatment and existing pharmacological and behavioural interventions often fail to produce durable recovery. Renewed interest in classic psychedelics as adjuncts to psychotherapy has been driven by historical trials with LSD and recent uncontrolled pilot work with psilocybin showing large within-group reductions in substance use; observational studies also report decreases in alcohol and drug use after naturalistic psychedelic experiences. Despite emerging clinical findings, psychological theories explaining how psychedelic-assisted therapy produces change remain underdeveloped, particularly regarding self-related processes such as self-compassion, mindfulness capacities, and emotion regulation that are plausibly relevant to addiction recovery. Agin-Liebes and colleagues set out to characterise psychological mechanisms of change attributed to a structured psilocybin-facilitated treatment for AUD by analysing semistructured interview narratives from a subset of participants enrolled in the first double-blind randomized controlled trial of psilocybin-assisted psychotherapy for AUD. The primary aim of this qualitative study was to illuminate participants' lived experiences before, during, and after psilocybin treatment, with special attention to affect regulation, self-compassion, and social connectedness as potential therapeutic processes supporting reductions in drinking.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Agin-Liebes, G., Nielson, E. M., Zingman, M., Kim, K., Haas, A., Owens, L. T., Rogers, U., & Bogenschutz, M. (2024). Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis. Psychology of Addictive Behaviors, 38(1), 101-113. https://doi.org/10.1037/adb0000935
References (30)
Papers cited by this study that are also in Blossom
Agin-Liebes, G. I., Ekman, E., Anderson, B. T. et al. · Journal of Humanistic Psychology (2021)
Agin-Liebes, G. I., Lancelotta, R., Uthaug, M. V. et al. · ACS Pharmacology and Translational Science (2021)
Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Bogenschutz, M. P., Podrebarac, S. K., Duane, J. H. et al. · Frontiers in Pharmacology (2018)
Bogenschutz, M. P., Ross, S., Bhatt, S. R. et al. · JAMA Psychiatry (2022)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)
Doering-Silveira, E., Lopez, E., Grob, C. S. et al. · Journal of Psychoactive Drugs (2005)
Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Human Psychopharmacology (2021)
Domínguez-Clavé, E., Soler, J., Pascual, J. C. et al. · Psychopharmacology (2018)
Show all 30 referencesShow fewer
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
Fábregas, J. M., González, D., Fondevila, S. et al. · Drug and Alcohol Dependence (2010)
Fauvel, B., Strika-Bruneau, L., Piolino, P. · Psychology of Consciousness Theory Research and Practice (2023)
Franquesa, A., Sainz-Cort, A., Gandy, S. et al. · Psychiatry Research (2018)
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Kirchner, K. · Journal of Psychopharmacology (2014)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Halpern, J. H., Sherwood, A. R., Passie, T. et al. · Medical Science Monitor (2008)
Hendricks, P. S. · International Review of Psychiatry (2018)
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Krebs, T. S., Johansen, P. Ø. · Journal of Psychopharmacology (2012)
Ross, S., Malone, T. C., Mennenga, S. E. et al. · Frontiers in Pharmacology (2018)
Nichols, D. E. · Pharmacological Reviews (2016)
Noorani, T., Garcia-Romeu, A., Swift, T. C. et al. · Journal of Psychopharmacology (2018)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Ruffell, S. G. D., Netzband, N., Tsang, W. et al. · Frontiers in Psychiatry (2021)
Sampedro, F., de la Fuente Revenga, M., Valle, M. et al. · International Journal of Neuropsychopharmacology (2017)
Stauffer, C., Anderson, B. T., Ortigo, K. M. et al. · ACS Pharmacology and Translational Science (2020)
Walsh, Z., Bird, B. M., Lafrance, A. et al. · Journal of Psychopharmacology (2018)
Cited By (2)
Papers in Blossom that reference this study
Ermakova, A. O., Dunbar, F., Seynaeve, M. et al. · Scientific Reports (2025)
Pagni, B. A., Petridis, P. D., Podrebarac, S. K. et al. · Scientific Reports (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.